All You Need To Know Going Into Trade On March 6
Asian stocks rallied, following gains in U.S. equities and the dollar, as concern eased on President Donald Trump's proposed tariffs.
The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index's performance in India, rose 0.6 percent to 10,423 as of 7:10 a.m.
Short on time? Well, then listen to this podcast for a quick summary of the article!
DayBreak
Here's a quick look at all that could influence equities on Tuesday.
Global Cues
- U.S. stocks rose with the dollar, while Treasuries fell as signs mounted that President Donald Trump's tough tariff talk may not translate into the most severe protectionist policies.
- Ten-year Treasury yields advanced toward 2.90 percent, while the greenback rose against most peers with the Canadian dollar leading declines.
#BQMarketsNow | Stocks rise on speculation trade threat is easing.https://t.co/EHwJf2AfyQ pic.twitter.com/b5T6SyfMYn
March 6, 2018Europe Check
- European stocks rebounded from a one-year low as technology firms rallied the most in 19 months.
Asian Cues
- Japan's Topix was up 1.8 percent and the Nikkei 225 Stock Average climbed 2.1 percent.
- Australia's S&P/ASX 200 Index added 1.3 percent.
- South Korea's Kospi index advanced 1.1 percent.
- Futures on Hong Kong's Hang Seng Index rose 1.2 percent.
- Contracts on the S&P 500 Index gained less than 0.05 percent.
Here are some key events coming up this week:
- The Chinese People's Political Consultative Conference runs through March 15 and overlaps with the National People's Congress meetings in Beijing, through March 20.
- Reserve Bank of Australia monetary policy decision on Tuesday, with GDP data due Wednesday.
- The ECB isn't expected to change policy on Thursday, but the Governing Council may discuss a change to pave the way for the end of quantitative easing.
- BOJ monetary policy decision and briefing on Friday.
- U.S. monthly payrolls data.
Nikkei snaps 4-day losing streak.https://t.co/EHwJf2AfyQ pic.twitter.com/sE8UizqRcH
March 6, 2018Commodity Cues
- West Texas Intermediate crude rose 0.2 percent to $62.67 a barrel after advancing 2.2 percent Monday.
- Gold was steady at $1,322.05 an ounce.
Indian ADRs
Stocks To Watch
- Bank of Baroda leaves MCLR unchanged for March.
- RBI imposes Rs 3 crore penalty on Axis Bank and Rs 2 crore penalty on Indian Overseas Bank for non-compliance of NPA classification norms.
- SBI Hong Kong confirms it has no exposure in PNB fraud case.
- HDFC QIP closes today. It has issued 1.03 crore equity shares at Rs 1,825 per share.
- Ramco Cements to acquire clinker grinding unit from Ramco Industries for Rs 17 crore.
- IndusInd Bank invoked 4.3 percent Jaypee Infra stake pledged by Jaiprakash Associates.
- Global Offshore defaults on unsecured demand loan from Axis Bank. The principal amount of Rs 11.26 crore plus interest is outstanding.
- Somany Ceramics board approved plan to merge three units of promoter group with itself.
- Arman Financial to raise Rs 50 crore through issue of 16.66 lakh compulsory convertible debentures at Rs 300 each to Saif Partners India.
- JSW Energy acquires JSW Electric Vehicles.
- Wanbury says U.S. FDA completes inspection of API facility with five observations.
U.S. FDA Form 483 observations regarding Sun Pharmaceutical's Halol Plant.https://t.co/jxMLzaXeH4 pic.twitter.com/pRiODzacAn
March 6, 2018Bulk Deals
- Fortis Healthcare: BNP Paribas Arbitrage bought 37.5 lakh shares or 0.7 percent equity at Rs 155.28 each.
- Punjab Alkalies & Chemicals: IDBI Bank sold 3.12 lakh shares or 1.2 percent equity at Rs 27.9 each.
BSE
- IDFC Imperial Equity Fund bought 6.54 lakh shares or 1.2 percent equity at Rs 799.99 each.
- IDFC Sterling Equity Fund bought 4 lakh shares or 0.7 percent equity at Rs 799.99 each.
- Nomura Asset Management sold 13.89 lakh shares or 2.6 percent equity at Rs 799.99 each.
IndusInd Bank has invoked 6 crore pledged shares of the crisis-hit Jaypee Infratech.https://t.co/DzdvQ2hbkR pic.twitter.com/W0fUJoHGVY
March 5, 2018Corporate Actions
- KPR Mill ex-date for determining buyback eligibility.
- MOIL and Unichem Labs last trading day before start of buyback period.
Who's Meeting Whom
- Shriram Transport Finance to meet Evenstar Capital on March 6.
- Purvankara to meet several fund houses including GMO, Fidelity, SBI MF and BNP Paribas on March 6.
- KDDL will be meeting investors/analysts on March 6.
- TCI express to meet several fund houses including White Oak Capital, MetLife, Bharti Axa Life Insurance on March 6–7.
- Cummins India to meet several fund houses including Axis MF, Jefferies India, JM Financial from March 6–13.
- PI Industries to meet Darkhorse Capital Fund on March 6.
- Container Corp to meet UK based fund, Alquity on March 7.
- Tata Steel to meet Blackrock International and TIA CREF Investment Management on March 7 and 12.
Airtel, Idea approach TDSAT against TRAI's predatory pricing norms.https://t.co/0QRu1cObda pic.twitter.com/1DlWZJqEJ1
March 5, 2018Insider Trades
- UPL Ltd promoter Shilpa P Sagar sold 46,000 shares from Feb. 28–March 1.
- L&T Infotech promoter L&T sold 1 lakh shares on March 1.
Rupee
- Rupee closed at 65.11/$ on Monday from 65.17/$ on Thursday.
Top Gainers And Losers
Index Trends
F&O Cues
- Nifty March futures closed trading at 10,365.6, premium of 7.6 points versus discount of 1.4 points.
- All series: Nifty open interest up 3 percent, Bank Nifty open interest unchanged
- India VIX ended at 15.3, up 9.4 percent.
- Max open interest for March series at 10,700 call strike (Open interest at 53.2 lakh, up 22 percent).
- Max open interest for March series at 10,400 Put (Open interest at 35.4 lakh, down 4 percent).
RBI to inject additional liquidity of Rs 1 lakh crore in March.https://t.co/hTMb7wQZSo pic.twitter.com/zhPFefpPmi
March 5, 2018F&O Ban
- In ban: Fortis Healthcare, HDIL, IDBI, Oriental Bank.
- No new stocks in or out of ban.
Only intraday positions can be taken in stocks which are in F&O ban. There is a penalty in case of rollover of these intraday positions.
Put-Call Ratio
- Nifty PCR at 1.21 from 1.28
- Nifty Bank PCR at 0.85 from 0.91
Stocks Seeing High Open Interest Change
Fund Flows
Brokerage Radar
HSBC on Godrej Properties
- Maintained ‘Buy'; raised price target to Rs 825 from Rs 750.
- Portfolio additions remain strong.
- Sales momentum doubles over previous year.
- Project additions much faster than sales.
- Room for significant sales growth still remains.
JP Morgan on BEL
- Initiated ‘Overweight' with price target of Rs 185
- BEL's growth supported by growing capital outlay on defense, focus on import substitution and modernization.
- Sizable nondefense & export opportunity to augment future growth.
- Order backlog of Rs 40,500 crore is 3.8 times trailing one-year sales.
- Valuation highly correlated with order inflows.
- Two big-ticket orders of Rs 6,000 crore each are close to award.
- Expect revenue, operating income and net profit to compound at 13 percent, 15 percent and 17 percent respectively over the fiscal 2018-2020.
- Share buybacks to drive improvement in return on equity and cash yield.
- BEL has superior organic growth prospects, higher margin profile and scope for further return on equity expansion.
Credit Suisse on Sun Pharma
- Maintained ‘Outperform' with price target of Rs 640.
- Halol observations not very serious.
- Clearance may not require a re-inspection.
- Still take 4-6 months for clearance of warning letter.
- Of the three, two observations are procedural in nature.
- Cut earnings per share for the next two fiscals by 8 percent and 2 percent respectively to factor Halol clearance by September.
India solar goal has a secret weapon.https://t.co/mUBRyngNTk pic.twitter.com/aTlbJyO0wZ
March 6, 2018
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.





